AGP Picks
View all

The Europe Daily Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Daily Report.

Press releases published on October 25, 2026

Business Elite Awards Celebrates Europe’s '40 Under 40' at Hotel Imperial Vienna
ENERABIA and Clearsun Energy sign MoU to commercialise Micro-CPV
PrintSheetLab Adds Free Math Calculators That Show Every Step
Falcon Fetches $100,000 at Saudi Arabia’s 2026 Falcon Auction
The Loft Bespoke Tailor Launches New Website With Fabric Library in Bangkok
Central Area Development Project in Hail, Saudi Arabia, to Open Next Wednesday
The Exhibition Hall of Achievements of China’s Language Resources Protection Project Officially Opens
MILIPOL QATAR 2026 CLOSES WITH 96 DEALS WORTH QAR 819 MILLION AND 10% RISE IN ATTENDANCE
SourceFoshan Is More Than Factory Visits: A Local Partner From Sourcing to Doorstep Delivery
P2PRadar: 9 of 10 European P2P Marketplaces Hold an EU License; 2 of 12 In-House Lenders Do
KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
Enrique Acosta Gonzalez Wins 'Podcaster of the Year' at Influencer Magazine Awards 2026
Dr. Sindhu Bhaskar Wins 'Social Impact Champion' at Influencer Magazine Awards 2026
Freddy Will Named Content Creator of the Year at the Influencer Magazine Awards 2026
Tarishi Suhalka Wins 'Industry Impact Award' at Influencer Magazine Awards 2026
Prof. Shabnam Delfani Wins 'International Recognition Award' at Influencer Magazine Awards 2026
Dr. Martha Boeckenfeld Named 'Tech Influencer of the Year' at the Influencer Magazine Awards 2026
Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
BioNTech und Bristol Myers Squibb präsentieren ermutigende Daten aus globaler Phase-2-Studie mit Pumitamig bei fortgeschrittenem nicht-kleinzelligem Lungenkrebs nach Progression der Erkrankung unter einer Immuntherapie und Chemotherapie
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Europe Daily Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.